区域性肝门阻断在Ⅲ型肝门部胆管癌根治性切除中的应用-附49例报告
Application and experience in radical excision of hilar cholangiocarcinoma by regional blocking of hepatic hilum:a report of 49 cases
目的 探讨区域性肝门阻断在Ⅲ型肝门部胆管癌根治性切除中的应用。 方法 回顾性分析2002年-2010年11月收治的49例III型肝门部胆管癌的临床资料,其中治疗组24例解剖第1、2、3肝门后进行区域性阻断后,行根治性切除;对照组25例不解剖第2、3肝门,行常规根治性切除。 结果 治疗组无围手术期死亡发生,术后发生胆漏2例,肺部感染2例,均经积极非手术治疗恢复。对照组围手术期死亡2例,肝断面出血1例,胆漏2例,肺部感染2例。术后获得随访40例,随访率为82%,平均生存时间26月(2~65月)。总胆红素≥300μmol/L的患者其并发症发生率明显高于胆红素<300μmol/L者(P<0.05)。 结论 当总胆红素≥300 μ mol/L时,手术前应作减黄处理;根治性切除是治疗肝门部胆管癌最有效的方法,区域性肝门阻断可明显降低手术出血量、死亡率及术后并发症的发生率。
Objective To summarize the experience in radical excision of hilar cholangiocarcinoma by regional blocking of hepatic hilum. Methods: The clinical data and long-term outcome of 49 cases of hilar cholangiocarcinoma were analyzed retrospectively, from 2002 to 2009. 24 cases (treatment team) were resected radically after anatomizing and blocking hepatic hilum. 25 cases (contrast team) were resected radically by normal way. Results In treatment team, 2 cases of bile leak and 2 cases of pulmonary infection were found and cured by non-operation ways. In contrast team, 2 cases of dead, 1 cases of bleeeding in hepatic cross-section, 2 cases of bile leak, 2 cases of pulmonary infection were found. 40 cases were visited. The average survival time was 26 months (2~65 months). Complications of the cases with high total bilirubin (≥300μmol/L)were higher than the lower (P<0.05). Conclusions The cases with high total bilirubin(≥300 u mol/L)should be treated before operation. The best prognosis can be achieved by radical excision for patient with hepatic hilar cholangiocarcinoma. The methods of regional blocking of hepatic hilum could decrease the volume of hemorrhage, death rate and occurrence of complications after operation.
Hepatic hilum /   / Bile duct neoplasm / Regional blocking of hepatic hilum / Hepatectomy
[1] 郑树国,董家鸿,黄志强,等.肝门部胆管癌外科20年经验回顾
[J].中国普通外科杂志,2001, 10 (1):6-10.
[2] Kondo S, Hirano S, Ambo Y, et al. Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: Results of a prospective study
[J].Ann Surg,2004,240(1):95-101.
[3] (此文献文题请核实) Zervous EE, Pearson H, Durkin AJ, et al. ln continuity hepaticresection for advanced hilar cholangiocarcinoma
[J]. Am J Surg, 2004,188:584-588.
[4] 马幼平,李恩山,陈孝平,等.肝门部胆管癌的诊治:附96例报告
[J].中国普通外科杂志,2008,
17 (8): 798-800.
[5] 梁力建,赖佳明,李绍强,等.103例肝门部胆管癌的外科手术切除治疗
[J],中华外科杂志,2006, 44 (13): 882-884.
[6] 何晓东,康维明.恶性梗阻性黄疽的术前胆道引流与Ⅱ期手术
[J].中国医刊, 2002, 37(12):14-16.
[7] Seyama Y, Kubota K, Sano K,et al. Long-term out-come of extended hemihepatectomy for hilar bile ductcancer with no mortality and high survival rate
[J].Ann Surg,2003,238(1):73-83.
[8] 张永杰.肝门部胆管癌可切除性的术中判断技巧
[J].中国实用外科杂志,2007, 27(1):93-95.
[9] Nagino M,Kamiya J, Arai T, et al. One hundred consecutive hepatobiliary resections for biliary hilarmalignancy: preoperative blood donation, blood loss, transfusion, and out-come
[J]. Surgery, 2005, 137(2):148-155.
[10] Nishio H, Nagino M, Oda K, et al. TNM classification for perihilar cholangiocarcinoma: comparison between 5th and 6th editions of the AJCC/UICC staging system
[J].Langenbecks Arch Surg, 2005, 390 (4):319-327.
[11] 曲辉,赵平,单毅. 肝门部胆管癌外科治疗进展
[J].临床外科杂志,2004,16(4):273-274.
/
〈 |
|
〉 |